GlaxoSmithKline
Funding totals
Funds documented as disbursed and received by GlaxoSmithKline from 2014 to 2022, including capacity-building and PHEIC-specific funding. Totals may not align due to incomplete reporting and documentation.
Funds disbursed2014–2016
| $560K | Total funds (USD) |
| $0 | Capacity-building funds, including JEE core capacities (USD) |
| $560K | PHEIC funds (USD) |
Funds received2014–2016
| $0 | Total funds (USD) |
| $0 | Capacity-building funds, including JEE core capacities (USD) |
| $0 | PHEIC funds (USD) |
Funds by top 10 JEE core capacities
Funds disbursed and received by GlaxoSmithKline for activities aligned to JEE 1.0. core capacities (see Technical appendix). Value may be less than the total identified for capacity-building shown above because not all capacity-building funds align with a specified JEE core capacity.
Funds disbursedGlaxoSmithKline | 2014–2016
Funds receivedGlaxoSmithKline | 2014–2016
No data available
Funds by PHEIC
Funds disbursed and received by GlaxoSmithKline for PHEIC-specific response.
Funds disbursedGlaxoSmithKline | 2014–2016
Funds receivedGlaxoSmithKline | 2014–2016
No data available
Top recipients and funders
Top 10 recipients to which GlaxoSmithKline disbursed funds, and top 10 funders from which GlaxoSmithKline received funds.
Top 10 recipients2014–2016
| Save the Children | $560K |
Top 10 funders2014–2016
No data available
